Clinical Trial Update: Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety and preliminary efficacy of Upatinib for active anal fistulas in Crohn's disease, with recruitment ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Fistula
• Crohn Disease

Drugs mentioned

• Upatinib (Upatinib)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn's Diseases, Active Anal Fistula | Phase 1 | Status: RECRUITING